Polymorphisms of estrogen receptors and risk of depression: therapeutic implications
- PMID: 22901010
- DOI: 10.2165/11635960-000000000-00000
Polymorphisms of estrogen receptors and risk of depression: therapeutic implications
Abstract
Accumulating evidence suggests the involvement of estrogen in depression. Estrogen can modulate neurotransmitter turnover, enhancing the levels of serotonin and noradrenaline (norepinephrine), and it is involved in the regulation of serotonin receptor number and function. Across the female reproductive life, fluctuating estrogen levels and low levels have been associated with depressed mood and there is strong support for a beneficial effect of estrogen-containing hormone treatment in depressed peri-menopausal women. Estrogen exerts its biological effects in large part through intracellular activation of its principal receptors, estrogen receptor α (ESR1) and estrogen receptor β (ESR2). Genetic variation in the estrogen receptors may therefore modify estrogen signalling, thus influencing a woman's susceptibility to developing depression. This review provides a synthesis of studies that have examined the association between estrogen receptor polymorphisms and depression-related mood disorders across the lifetime. Studies were identified through a search of the literature from January 1980 until March 2012 using MEDLINE, Web of Knowledge, Cochrane Library and PsycINFO databases. The studies conducted to date have produced inconsistent findings, which likely relates to the large heterogeneity in terms of the populations, study design and depression measures used. It appears unlikely that the common ESR1 variants rs2234693 and rs9340799 are associated with moderate depressive symptoms in women; however, there is some evidence that indicates a significant association with more severe depressive symptoms, major depressive disorder and anxiety. There are too few studies of ESR2 polymorphisms to draw any definite conclusions; however, preliminary evidence suggests that specific variants may modify the risk of depression associated with the use of hormone treatment in women. Few studies have investigated associations in men, and they have focused almost exclusively on ESR1, but all report non-significant findings. Much work is therefore still needed in this field. If it is confirmed that specific estrogen receptor polymorphisms are associated with the risk of depression, this could have important preventive and therapeutic implications, with the potential to develop targeted estrogen receptor agonists and antagonists. Furthermore, it is possible that such therapies may be more effective in treating particular people with depression based on their genetic profile, which is an exciting prospect given that many people do not respond to current antidepressant treatments.
Similar articles
-
The role of allelic variation in estrogen receptor genes and major depression in the Nurses Health Study.Soc Psychiatry Psychiatr Epidemiol. 2015 Dec;50(12):1893-904. doi: 10.1007/s00127-015-1087-1. Epub 2015 Jul 14. Soc Psychiatry Psychiatr Epidemiol. 2015. PMID: 26169989 Free PMC article.
-
The influence of ESR1 rs9340799 and ESR2 rs1256049 polymorphisms on prostate cancer risk.Tumour Biol. 2014 Aug;35(8):8319-28. doi: 10.1007/s13277-014-2086-7. Epub 2014 May 24. Tumour Biol. 2014. PMID: 24859835
-
Estrogen receptor gene variants are associated with anxiety disorders in older women.Psychoneuroendocrinology. 2011 Nov;36(10):1582-6. doi: 10.1016/j.psyneuen.2011.04.011. Epub 2011 May 12. Psychoneuroendocrinology. 2011. PMID: 21570196
-
A review of estrogen receptor alpha gene (ESR1) polymorphisms, mood, and cognition.Menopause. 2010 Jul;17(4):874-86. doi: 10.1097/gme.0b013e3181df4a19. Menopause. 2010. PMID: 20616674 Free PMC article. Review.
-
Genetic variation of estrogen metabolism and the risks of cardiovascular disease.Curr Opin Investig Drugs. 2007 Oct;8(10):814-20. Curr Opin Investig Drugs. 2007. PMID: 17907057 Review.
Cited by
-
Depression in Women: Potential Biological and Sociocultural Factors Driving the Sex Effect.Neuropsychobiology. 2024;83(1):2-16. doi: 10.1159/000531588. Epub 2024 Jan 25. Neuropsychobiology. 2024. PMID: 38272005 Free PMC article. Review.
-
The sex-dependent response to psychosocial stress and ischaemic heart disease.Front Cardiovasc Med. 2023 Apr 21;10:1072042. doi: 10.3389/fcvm.2023.1072042. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37153459 Free PMC article. Review.
-
Bioinformatics and computational chemistry approaches to explore the mechanism of the anti-depressive effect of ligustilide.Sci Rep. 2023 Apr 3;13(1):5417. doi: 10.1038/s41598-023-32495-7. Sci Rep. 2023. PMID: 37012370 Free PMC article.
-
Potential mechanisms underlying the therapeutic roles of sinisan formula in depression: Based on network pharmacology and molecular docking study.Front Psychiatry. 2022 Nov 9;13:1063489. doi: 10.3389/fpsyt.2022.1063489. eCollection 2022. Front Psychiatry. 2022. PMID: 36440424 Free PMC article.
-
Identification of potential Mitogen-Activated Protein Kinase-related key genes and regulation networks in molecular subtypes of major depressive disorder.Front Psychiatry. 2022 Oct 21;13:1004945. doi: 10.3389/fpsyt.2022.1004945. eCollection 2022. Front Psychiatry. 2022. PMID: 36339846 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous